Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Second generation non-sedative antihistaminics]

N Bakos1

  • 1Debreceni Orvostudományi Egyetem, Börklinika.

Orvosi Hetilap
|July 3, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: long-term safety and efficacy in an open-label extension study.

The British journal of dermatology·2018
Same author

Social instability in female rats: the relationship between stress-related and anxiety-like consequences.

Physiology & behavior·2005
Same author

Stress, social avoidance and anxiolytics: a potential model of stress-induced anxiety.

Behavioural pharmacology·2003
Same author

High prevalence of IgG and IgA antibodies to 19-kDa Helicobacter pylori-associated lipoprotein in chronic urticaria.

Allergy·2003
Same author

Stress-induced social avoidance: a new model of stress-induced anxiety?

Physiology & behavior·2002
Same author

The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.

The European journal of neuroscience·2002
Same journal

[Hungarian primary care: facts, problems and expectations].

Orvosi hetilap·2026
Same journal

[The role of obesity and weight reduction in obstructive sleep apnea].

Orvosi hetilap·2026
Same journal

[Mucinous cystic neoplasm of the liver].

Orvosi hetilap·2026
Same journal

[Towards the elimination of iodine deficiency in Hungary].

Orvosi hetilap·2026
Same journal

[Predictive factors of vocal cord paralysis following thyroid surgery].

Orvosi hetilap·2026
Same journal

[Letter to the editor].

Orvosi hetilap·2026
See all related articles

Second-generation antihistamines offer improved efficacy and reduced side effects compared to older drugs. These modern antihistamines are selective, peripherally acting H1 receptor antagonists with significant clinical importance.

Area of Science:

  • Pharmacology
  • Allergy and Immunology

Context:

  • Development of antihistamines in the 1980s led to improved efficacy and fewer side effects.
  • Second-generation antihistamines emerged with specific pharmacokinetic and pharmacodynamic profiles.

Purpose:

  • To outline the essential characteristics of modern, second-generation antihistamines.
  • To review the pharmacokinetic properties and clinical significance of these advanced antihistamines.

Summary:

  • Modern antihistamines should be selective, peripheral H1 receptor antagonists with low central nervous system affinity.
  • Key properties include lack of anticholinergic/antiserotonin effects, mast cell stabilization, and inhibition of eosinophil activity.
  • Examples include terfenadine, astemizole, loratadine, and cetirizine, introduced from 1985 onwards.

Related Experiment Videos

Impact:

  • These advancements provide a better understanding of antihistamine development and their therapeutic applications.
  • Highlights the clinical importance and pharmacokinetic profiles of second-generation antihistamines for treating allergic conditions.